Wound healing and local neuroendocrine regulation in the injured liver
- PMID: 18442446
- DOI: 10.1017/S146239940800063X
Wound healing and local neuroendocrine regulation in the injured liver
Abstract
The hepatic wound-healing response is a complex process involving many different cell types and factors. It leads to the formation of excessive matrix and a fibrotic scar, which ultimately disrupts proper functioning of the liver and establishes cirrhosis. Activated hepatic myofibroblasts, which are derived from cells such as hepatic stellate cells (HSCs), play a key role in this process. Upon chronic liver injury, there is an upregulation in the local neuroendocrine system and it has recently been demonstrated that activated HSCs express specific receptors and respond to different components of this system. Neuroendocrine factors and their receptors participate in a complex network that modulates liver inflammation and wound healing, and controls the development and progression of liver fibrosis. The first part of this review provides an overview of the molecular mechanisms governing hepatic wound healing. In the second section, we explore important components of the hepatic neuroendocrine system and their recently highlighted roles in HSC biology and hepatic fibrogenesis. We discuss the therapeutic interventions that are being developed for use in antifibrotic therapy.
Similar articles
-
Hepatic stellate cells as a target for the treatment of liver fibrosis.Semin Liver Dis. 2001 Aug;21(3):437-51. doi: 10.1055/s-2001-17558. Semin Liver Dis. 2001. PMID: 11586471 Review.
-
The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis.Apoptosis. 2005 Oct;10(5):927-39. doi: 10.1007/s10495-005-1055-4. Apoptosis. 2005. PMID: 16151628 Review.
-
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.Liver Int. 2008 Sep;28(8):1052-64. doi: 10.1111/j.1478-3231.2008.01825.x. Liver Int. 2008. PMID: 18783548 Review.
-
Fibrosis in the liver: acute protection and chronic disease.Prog Mol Biol Transl Sci. 2010;97:151-200. doi: 10.1016/B978-0-12-385233-5.00006-4. Prog Mol Biol Transl Sci. 2010. PMID: 21074733 Review.
-
Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1024-35. doi: 10.1111/j.1440-1746.2008.05345.x. Epub 2008 May 26. J Gastroenterol Hepatol. 2008. PMID: 18505415 Review.
Cited by
-
Effect of antioxidant treatment on fibrogenesis in rats with carbon tetrachloride-induced cirrhosis.ISRN Gastroenterol. 2012;2012:762920. doi: 10.5402/2012/762920. Epub 2012 Apr 2. ISRN Gastroenterol. 2012. PMID: 22577570 Free PMC article.
-
Cholangiocyte proliferation and liver fibrosis.Expert Rev Mol Med. 2009 Feb 25;11:e7. doi: 10.1017/S1462399409000994. Expert Rev Mol Med. 2009. PMID: 19239726 Free PMC article. Review.
-
Evolving challenges in hepatic fibrosis.Nat Rev Gastroenterol Hepatol. 2010 Aug;7(8):425-36. doi: 10.1038/nrgastro.2010.97. Epub 2010 Jun 29. Nat Rev Gastroenterol Hepatol. 2010. PMID: 20585339 Review.
-
Bioreactor technologies to support liver function in vitro.Adv Drug Deliv Rev. 2014 Apr;69-70:132-57. doi: 10.1016/j.addr.2014.02.011. Epub 2014 Mar 5. Adv Drug Deliv Rev. 2014. PMID: 24607703 Free PMC article. Review.
-
Cholinergic Anti-Inflammatory Pathway and the Liver.Adv Pharm Bull. 2017 Dec;7(4):507-513. doi: 10.15171/apb.2017.063. Epub 2017 Dec 31. Adv Pharm Bull. 2017. PMID: 29399541 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources